GOSS
Price
$0.77
Change
-$0.04 (-4.94%)
Updated
Apr 19, 2:08 PM EST
25 days until earnings call
PCVX
Price
$60.62
Change
-$0.00 (-0.00%)
Updated
Apr 19, 2:22 PM EST
17 days until earnings call
Ad is loading...

Compare predictions GOSS vs PCVX

Header iconGOSS vs PCVX Comparison
Open Charts GOSS vs PCVXBanner chart's image
Gossamer Bio
Price$0.77
Change-$0.04 (-4.94%)
Volume$500
CapitalizationN/A
Vaxcyte
Price$60.62
Change-$0.00 (-0.00%)
Volume$2.62K
CapitalizationN/A
View a ticker or compare two or three
GOSS vs PCVX Comparison Chart

Loading...

GOSSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
PCVXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
GOSS vs. PCVX commentary
Apr 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GOSS is a Hold and PCVX is a Hold.

COMPARISON
Comparison
Apr 19, 2024
Stock price -- (GOSS: $0.81 vs. PCVX: $60.62)
Brand notoriety: GOSS and PCVX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GOSS: 50% vs. PCVX: 94%
Market capitalization -- GOSS: $180.47M vs. PCVX: $6.59B
GOSS [@Biotechnology] is valued at $180.47M. PCVX’s [@Biotechnology] market capitalization is $6.59B. The market cap for tickers in the [@Biotechnology] industry ranges from $553.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.51B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GOSS’s FA Score shows that 0 FA rating(s) are green whilePCVX’s FA Score has 0 green FA rating(s).

  • GOSS’s FA Score: 0 green, 5 red.
  • PCVX’s FA Score: 0 green, 5 red.
According to our system of comparison, PCVX is a better buy in the long-term than GOSS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GOSS’s TA Score shows that 4 TA indicator(s) are bullish while PCVX’s TA Score has 3 bullish TA indicator(s).

  • GOSS’s TA Score: 4 bullish, 5 bearish.
  • PCVX’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, both GOSS and PCVX are a bad buy in the short-term.

Price Growth

GOSS (@Biotechnology) experienced а -16.69% price change this week, while PCVX (@Biotechnology) price change was -6.49% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.43%. For the same industry, the average monthly price growth was -4.72%, and the average quarterly price growth was +1227.14%.

Reported Earning Dates

GOSS is expected to report earnings on Aug 06, 2024.

PCVX is expected to report earnings on Aug 06, 2024.

Industries' Descriptions

@Biotechnology (-6.43% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for GOSS with price predictions.
OPEN
A.I.dvisor published
a Summary for PCVX with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
PCVX($6.59B) has a higher market cap than GOSS($180M). PCVX YTD gains are higher at: -3.471 vs. GOSS (-11.671).
GOSSPCVXGOSS / PCVX
Capitalization180M6.59B3%
EBITDAN/AN/A-
Gain YTD-11.671-3.471336%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
GOSSPCVX
RSI
ODDS (%)
Bullish Trend 2 days ago
83%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
80%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 19 days ago
81%
Bullish Trend 24 days ago
81%
Declines
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 19 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
81%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Ad is loading...
GOSSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
PCVXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FDD11.660.03
+0.22%
First Trust STOXX® European Sel Div ETF
RSPE24.26-0.01
-0.03%
Invesco ESG S&P 500 Equal Weight ETF
RSEE26.84-0.03
-0.11%
Rareview Systematic Equity ETF
KOKU88.58-0.28
-0.32%
Xtrackers MSCI Kokusai Equity ETF
IOO86.34-0.30
-0.35%
iShares Global 100 ETF

GOSS and

Correlation & Price change

A.I.dvisor indicates that over the last year, GOSS has been loosely correlated with MEIP. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if GOSS jumps, then MEIP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GOSS
1D Price
Change %
GOSS100%
-1.71%
MEIP - GOSS
46%
Loosely correlated
-1.81%
CGEM - GOSS
45%
Loosely correlated
+1.01%
VIR - GOSS
44%
Loosely correlated
-3.52%
SYRE - GOSS
41%
Loosely correlated
+3.70%
APVO - GOSS
41%
Loosely correlated
+8.07%
More

PCVX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PCVX has been loosely correlated with FOLD. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if PCVX jumps, then FOLD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PCVX
1D Price
Change %
PCVX100%
-2.90%
FOLD - PCVX
47%
Loosely correlated
-2.09%
INZY - PCVX
45%
Loosely correlated
-1.51%
MLYS - PCVX
45%
Loosely correlated
-10.42%
INBX - PCVX
44%
Loosely correlated
-0.46%
XNCR - PCVX
44%
Loosely correlated
-0.63%
More